Syndax Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

26.02.18	Syndax to Announce Fourth Quarter and Year-end 2017 Financial Results and Host Conference Call and Webcast on March 5, 2018 (PR Newswire)
22.02.18	Syndax Announces Presentations at the 2018 American Association for Cancer Research Annual Meeting (PR Newswire)
01.02.18	Syndax Announces Immuno-Oncology Clinical Trial Collaboration with AstraZeneca (PR Newswire)
10.01.18	Syndax Pharmaceuticals Announces Clinical Collaboration to Evaluate Entinostat in Combination with anti-PD-L1 Cancer Immunotherapy in Breast Cancer (PR Newswire)
14.11.17	NKTR's Pivot Data Pleases Investors, OPHT Catches Eyes, CALA Craters, Wave Rises (RTTNews)
11.11.17	Syndax Pharmaceuticals Announces Presentation of Data from Immuno-oncology Clinical Trials at the Society for Immunotherapy of Cancer 32nd Annual Scientific Meeting (PR Newswire)
07.11.17	Syndax Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Clinical and Business Update (PR Newswire)
07.11.17	Syndax to Present at the SITC 32nd Annual Scientific Meeting (PR Newswire)
31.10.17	Syndax to Announce Third Quarter 2017 Financial Results and Host Conference Call and Webcast on November 7, 2017 (PR Newswire)
17.10.17	Syndax Expands Pipeline with Exclusive Worldwide License to Allergan's Portfolio of Menin-MLL Inhibitors (PR Newswire)
05.10.17	Syndax Announces Dosing of First Patient in Pivotal Trial of Entinostat for the Treatment of Advanced or Recurrent Breast Cancer in Japan by Partner Kyowa Hakko Kirin (PR Newswire)
20.09.17	Syndax Pharmaceuticals Announces Updated Presentation Time at the Cantor Fitzgerald Global Healthcare Conference (PR Newswire)
30.08.17	Syndax Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences (PR Newswire)
10.08.17	Syndax Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Clinical and Business Update (PR Newswire)
03.08.17	Syndax to Announce Second Quarter 2017 Financial Results and Host Conference Call and Webcast on August 10, 2017 (PR Newswire)
11.07.17	Preclinical Results Support Entinostat's Role in Targeting the Tumor Microenvironment to Enhance Immune Checkpoint Therapy (PR Newswire)
26.05.17	Gainers & Losers Of May 25: AERI, BCRX, NEOT, SNDX, SYRS... (RTTNews)
24.05.17	MRK's Keytruda Scores Another FDA Nod, NBIX Disappoints, SBPH Achieves It (RTTNews)
18.05.17	SNDX Rises On Entinostat Data, Kalydeco Gets FDA Nod, Concert Fails To Enthrall (RTTNews)
18.05.17	Gainers & Losers Of May 17: SNDX, PULM, PBYI, CNCE, XLRN... (RTTNews)
31.03.16	Syndax Shares Up Sharply After Upgrade (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Lonza Grp	548.20	4.94 %	K V
CieFinRichemont	135.60	1.46 %	K V
UBS Group	28.62	1.13 %	K V
Holcim	90.18	1.08 %	K V
Alcon	76.56	0.63 %	K V
Swiss Re	127.80	-0.31 %	K V
Sika	230.60	-0.60 %	K V
Swiss Life Hldg	687.20	-0.66 %	K V
Part Grp Hldg	1’284.50	-0.96 %	K V
Kuehne+Nagel Int	205.00	-2.80 %	K V

Nachrichten zu Syndax Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten